|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Loss before tax | |||||
| Depreciation charges | |||||
| Amortization charges | |||||
| Charge for the year in respect of share-based payments | |||||
| Net foreign exchange (gain)/loss | |||||
| Finance and other expenses | |||||
| Finance and other income | |||||
| (Increase)/decrease in trade and other receivables | |||||
| Increase in other current assets | |||||
| (Increase) in R&D tax credit receivable | |||||
| (Increase) in other long term current assets | |||||
| Increase in trade and other payables | |||||
| (Decrease)/increase in contract liabilities | |||||
| Cash generated/(spent) on operations | |||||
| Tax paid | |||||
| R&D tax credits received | |||||
| Net cash (outflow)/inflow from operating activities | |||||
| Redemption of financial assets at amortized cost - term deposits | |||||
| Purchase of financial assets at amortized cost | |||||
| Interest received | |||||
| Purchase of property, plant and equipment | |||||
| Net cash (outflow)/inflow from investing activities | |||||
| Repayment of lease liabilities | |||||
| Proceeds from issue of share capital | |||||
| Net cash inflow from financing activities | |||||
| Cash and cash equivalents at start of year | |||||
| Cash and cash equivalents at end of year | |||||
| Cash flow from operating activities | |||||
| Net loss after tax | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation expense | |||||
| Amortization expense | |||||
| Share-based compensation expense | |||||
| Net foreign exchange impacts | |||||
| Other income, net | |||||
| Income tax expense | |||||
| Change in operating assets and liabilities: | |||||
| Decrease/(increase) in trade receivables | |||||
| Decrease/(increase) in other current assets | |||||
| Decrease/(increase) in R&D benefit receivable | |||||
| Decrease in other long-term assets | |||||
| (Decrease)/increase in trade and other payables | |||||
| Decrease in contract liabilities | |||||
| Decrease in operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flow from investing activities | |||||
| Redemption of term deposits | |||||
| Purchase of term deposits | |||||
| Purchase of property, plant and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flow from financing activities | |||||
| Proceeds from issue of ordinary shares | |||||
| Net cash provided by financing activities | |||||
| (Decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents at start of period | |||||
| Effect of exchange rate fluctuations on cash and cash equivalents held | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Income Tax Paid net of refunds | |||||
Loading...